Post by
Forestview on Jan 12, 2021 2:42pm
Still can't believe
This company is posed for Phase 3 on a groundbreaking drug, and the market cap is only $160M.
Ridiculous.
Comment by
Layth1990 on Jan 12, 2021 2:55pm
partnering with big pharma and nasdaq listing will make this fly.
Comment by
MrMugsy on Jan 12, 2021 3:44pm
------- Agreed ... it's frustrating. But we're now entering a place we've never been before - we're negotiating with various companies and we know that ATE doesn't want to go into Phase 3 on its own. We also know the family of drugs are impressive so it should get attention from many parties. The rest if rather blurry ... hahaha!